+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Respiratory Care Device Market Report and Forecast 2024-2032

  • PDF Icon

    Report

  • 200 Pages
  • August 2024
  • Region: Global
  • Expert Market Research
  • ID: 5997759
The global respiratory care device market reached a value of around USD 21.67 billion in 2023, fuelled by the rise in severe respiratory diseases across the globe. The market is expected to grow at a CAGR of 8.60% during the forecast period of 2024-2032 and expected to attain a market value of around USD 45.3 billion by 2032.

Global Respiratory Care Device Market Analysis

The global respiratory care device market is a rapidly evolving sector, driven by increasing respiratory ailments, technological advancements, and a growing elderly population.

Market Drivers

  • Rising Prevalence of Respiratory Diseases: The primary driver for the respiratory care device market is the increasing incidence of respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and sleep apnea. Urbanization and rising pollution levels further exacerbate these conditions, boosting demand for respiratory care devices.
  • Aging Population: Older adults are more susceptible to respiratory diseases due to weakened immune systems and reduced lung capacity. With the global population aging, the demand for respiratory care is expected to increase significantly.
  • Technological Advancements: Innovations in respiratory care devices, such as smart inhalers and portable ventilators, are enhancing patient outcomes and compliance. These advancements are making treatments more efficient and user-friendly, thereby increasing their adoption.
  • COVID-19 Impact: The COVID-19 pandemic has brought unprecedented attention to respiratory health, leading to a surge in demand for respiratory care devices, especially ventilators and airway management devices, to treat virus-infected patients.
  • Healthcare Expenditure and Insurance Coverage: Increasing healthcare spending and better insurance coverage for respiratory therapies and devices are making treatments more accessible, thus driving market growth.

Challenges

  • High Cost of Devices: Advanced respiratory care devices can be expensive, making them less accessible in low- and middle-income countries. This cost factor is a significant barrier to the adoption of newer technologies.
  • Regulatory Hurdles: Stringent regulatory requirements for the approval of medical devices can delay product launches and add to development costs. This regulatory environment can inhibit the growth of the respiratory care devices market.
  • Limited Awareness in Emerging Economies: In many developing regions, there is limited awareness about the latest respiratory care devices and their benefits, which hinders market penetration.
  • Reimbursement Issues: Inconsistent reimbursement policies for respiratory therapies and devices can affect market growth, as patients might forego advanced treatments due to out-of-pocket costs.

Future Opportunities

  • Emerging Markets: Developing countries present significant opportunities for the respiratory care device market due to rising healthcare infrastructure, increasing disposable incomes, and growing awareness about respiratory health.
  • Home Care Respiratory Devices: There is a growing trend towards home healthcare, driven by the patient preference for receiving care in the comfort of their own homes. This shift is expected to increase the demand for portable and easy-to-use respiratory devices.
  • Integration of Artificial Intelligence: AI and machine learning are being integrated into respiratory devices to provide insights into patient health trends and improve device functionality. This technological integration represents a key area of growth.
  • Sustainable and Advanced Materials: Development of devices using sustainable materials that reduce environmental impact and enhance patient compatibility can open new avenues for innovation and market expansion.
  • Collaborations and Mergers: Strategic alliances and mergers between key players can lead to better R&D capabilities, enhanced market reach, and expanded product portfolios, driving further growth in the sector.
The global respiratory care device market is positioned for continued growth, driven by demographic changes, technological advancements, and the ongoing impact of the COVID-19 pandemic. Despite facing challenges such as high costs and regulatory complexities, the market is ripe with opportunities for expansion, especially in emerging economies and through technological innovations.

Global Respiratory Care Device Market Trends

The global respiratory care device market is experiencing significant growth due to increasing health awareness and advancements in medical technology. As populations age and environmental factors impact respiratory health, the demand for innovative and effective respiratory solutions continues to surge. Here are some key market trends:
  • Shift Towards Portable Devices: There's a growing preference for portable respiratory care devices, driven by the increasing demand for home healthcare services. Portable devices like handheld inhalers, compact nebulizers, and lightweight oxygen concentrators are becoming more popular as they offer patients the freedom to maintain their mobility and lifestyle.
  • Smart Technology Integration: Respiratory devices are increasingly being integrated with smart technologies that enable remote monitoring and data analysis. Features such as Wi-Fi connectivity and compatibility with mobile apps allow healthcare providers to monitor patients' conditions in real-time, enhancing treatment efficacy and patient engagement.
  • Focus on Customization and Patient Comfort: Manufacturers are focusing on developing devices that are not only effective but also comfortable for long-term use. This includes features like improved mask fits for CPAP machines and quieter operation, which enhance user compliance and comfort.
  • Expansion of Product Range and Applications: Companies are expanding their product portfolios to include a wider range of treatment options, catering to various respiratory conditions from mild asthma to severe COPD. This diversification helps companies tap into broader markets and meet specific patient needs.
  • Regulatory and Standardization Advances: There is an increasing emphasis on meeting stringent regulatory standards and achieving certifications that ensure the safety and effectiveness of respiratory devices. Compliance with these standards is crucial for market entry and expansion, particularly in regulated markets like the US and Europe.
These trends highlight the dynamic nature of the respiratory care device market, where ongoing innovation and adaptation are key to meeting the evolving needs of the global population.

Global Respiratory Care Device Market Segmentation

Market Breakup by Product

  • Therapeutic Respiratory Care Devices
  • Positive Airway Pressure (PAP) Devices
  • Oxygen Concentrator
  • Ventilators
  • Inhalers
  • Nebulizers
  • Humidifiers
  • Reusable Resuscitators
  • Nitric Oxide Delivery Units
  • Oxygen Hoods
  • Respiratory Care Monitoring Devices
  • Pulse Oximeter
  • Capnography
  • Gas Analyzers
  • Diagnostic Respiratory Care Devices
  • Spirometer
  • Polysomnography Devices
  • Peak Flow Meter
  • Others
The respiratory care device market is segmented into therapeutic, monitoring, and diagnostic devices, each poised for significant growth due to diverse drivers. Therapeutic devices, including PAP devices, ventilators, and inhalers, are expanding due to the rising prevalence of respiratory diseases and aging populations, ensuring continued demand. Monitoring devices like pulse oximeters and capnographs are crucial for managing chronic conditions and have seen increased adoption in home care settings, spurred by the COVID-19 pandemic. Diagnostic devices such as spirometers and polysomnography devices are critical for early disease detection and management. Across these segments, technological advancements and a shift towards portable and smarter products are set to drive substantial market growth during the forecast period.

Market Breakup by Disease Indications

  • COPD
  • Asthma
  • Sleep Apnea
  • Infectious Disease
  • Others
The respiratory care device market is segmented by disease indications, with each segment contributing to market growth driven by specific clinical needs and patient demographics. Devices targeting COPD are in high demand due to the global increase in smoking and pollution levels, which elevate the prevalence of this chronic condition. Asthma-related devices, especially inhalers and nebulizers, are essential due to rising global incidence and the need for effective symptom management. The sleep apnea segment is growing rapidly, fueled by the rising awareness of the disorder and advancements in non-invasive treatment devices like CPAP machines. Devices for infectious diseases have seen a significant uptick, particularly during the COVID-19 pandemic, with ventilators and oxygen concentrators being critical. The 'others' category, which includes varied respiratory conditions, continues to push for innovations in treatment and monitoring technologies. Overall, each disease segment drives market growth by addressing specific therapeutic and diagnostic needs, aligning with global health trends and technological advancements.

Market Breakup by End User

  • Hospitals and Clinics
  • Home Care
  • Ambulatory Care
  • Others
The respiratory care device market is diversified across various end-user segments, each contributing uniquely to market dynamics and growth. Hospitals and clinics are the largest segment, leveraging advanced respiratory devices for acute care and emergency services, driven by the need for sophisticated ventilators and oxygen delivery systems, particularly highlighted during health crises like the COVID-19 pandemic. The home care segment is experiencing rapid growth, propelled by the increasing preference for home healthcare solutions and the development of portable and user-friendly devices such as nebulizers and oxygen concentrators. Ambulatory care services are expanding as well, with a focus on cost-effective and efficient patient care outside traditional hospital settings, increasing the use of mobile respiratory monitoring and therapy devices. The Others category, which includes long-term care facilities and emergency medical services, also relies on these devices for comprehensive respiratory support, underlining the crucial role of technology in managing respiratory conditions across diverse care settings. Each segment is poised to drive significant market growth in the forecast period, with ongoing innovations and a shift towards personalized and accessible respiratory care solutions.

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
The respiratory care device market is segmented across key global regions, each displaying unique growth dynamics influenced by regional healthcare infrastructures, economic conditions, and demographic trends.

North America leads the market, driven by advanced healthcare systems, high healthcare expenditure, and a strong presence of leading respiratory device manufacturers. The region's focus on innovative technologies and the high prevalence of respiratory diseases further stimulate market growth.
Europe follows closely, with a robust healthcare framework and substantial investments in healthcare research and development. The region's aging population and increasing air pollution contribute significantly to the demand for respiratory care devices.

Asia Pacific is the fastest-growing region, fueled by rising healthcare awareness, increasing disposable incomes, and healthcare infrastructure improvements in emerging economies like China and India. The increasing burden of respiratory diseases in this densely populated region also drives demand.
Latin America and the Middle East and Africa are expected to witness substantial growth due to the expanding healthcare sectors and increasing government initiatives to improve healthcare accessibility. These regions are increasingly adopting respiratory care devices to address a growing prevalence of respiratory conditions and improving the overall healthcare landscape.

Each region contributes to the global market's expansion, with North America and Asia Pacific leading in technology adoption and market size, respectively, while emerging markets in Latin America and the Middle East and Africa present significant growth opportunities due to evolving healthcare needs and economic development.

Global Respiratory Care Device Market Competitive Landscape

The competitive landscape of the global respiratory care device market is dynamic, featuring a mix of established companies and innovative newcomers that actively engage in various strategic activities to strengthen their market positions. Koninklijke Philips N.V. and ResMed Inc. are at the forefront, regularly introducing advanced products and participating in mergers and acquisitions to expand their global footprint. Masimo Corporation and General Electric Company emphasize research and development to innovate new solutions that enhance patient outcomes. Teleflex Incorporated, Fisher & Paykel Healthcare Corporation Limited, and Hamilton Medical AG focus on expanding their product lines and entering new markets through strategic partnerships and acquisitions. ICU Medical Inc. and Getinge AB concentrate on broadening their reach with new and upgraded products, backed by strong R&D investments. Aerin Medical Inc. and VitalAire Canada Inc. are smaller players but are progressively making their mark through niche product innovations and regional expansion efforts. Collectively, these activities help drive the market's growth, addressing an increasing demand for respiratory care solutions worldwide.

Key Questions Answered in the Report

  • What is the current and future performance of the respiratory care device market?
  • What are the main challenges facing the respiratory care device market?
  • What are the key drivers of the respiratory care device market?
  • What emerging trends are shaping the future of the respiratory care device market?
  • How are aging populations influencing the demand for therapeutic respiratory devices?
  • How do smoking and pollution levels impact the demand for COPD-targeting devices?
  • What factors are driving the demand for respiratory care devices in Europe?
  • Why are portable respiratory care devices becoming more popular in home healthcare?
  • How are Aerin Medical Inc. and VitalAire Canada Inc. impacting the respiratory care market?

Key Benefits for Stakeholders

  • The industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the global respiratory care device market from 2017-2032.
  • The research report provides the latest information on the market drivers, challenges, and opportunities in the respiratory care device market.
  • The study maps the leading, as well as the fastest-growing, regional markets. It further enables stakeholders to identify the key country-level markets within each region.
  • Porter's five forces analysis assists stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the global respiratory care device industry and its attractiveness.
  • The competitive landscape allows stakeholders to understand their competitive environment and provides insight into the current positions of key players in the market.


This product will be delivered within 5-7 business days.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Respiratory Care Device Market Overview
3.1 Global Respiratory Care Device Market Historical Value (2017-2023)
3.2 Global Respiratory Care Device Market Forecast Value (2024-2032)
4 Vendor Positioning Analysis
4.1 Key Vendors
4.2 Prospective Leaders
4.3 Niche Leaders
4.4 Disruptors
5 Global Respiratory Care Device Market Landscape*
5.1 Global Respiratory Care Device: Developers Landscape
5.1.1 Analysis by Year of Establishment
5.1.2 Analysis by Company Size
5.1.3 Analysis by Region
5.2 Global Respiratory Care Device: Product Landscape
5.2.1 Analysis by Type
5.2.2 Analysis by Disease Indication
6 Global Respiratory Care Device Market Dynamics
6.1 Market Drivers and Constraints
6.2 SWOT Analysis
6.2.1 Strengths
6.2.2 Weaknesses
6.2.3 Opportunities
6.2.4 Threats
6.3 PESTEL Analysis
6.3.1 Political
6.3.2 Economic
6.3.3 Social
6.3.4 Technological
6.3.5 Legal
6.3.6 Environment
6.4 Porter’s Five Forces Model
6.4.1 Bargaining Power of Suppliers
6.4.2 Bargaining Power of Buyers
6.4.3 Threat of New Entrants
6.4.4 Threat of Substitutes
6.4.5 Degree of Rivalry
6.5 Key Demand Indicators
6.6 Key Price Indicators
6.7 Industry Events, Initiatives, and Trends
6.8 Value Chain Analysis
7 Global Respiratory Care Device Market, Epidemiology Snapshot
7.1 Overview of Global Respiratory Disease Incidence Number (2017-2032)
7.2 Incidence Number, By Indication (2017-2032)
7.2.1.1 COPD
7.2.1.2 Asthma
7.2.1.3 Sleep Apnea
7.2.1.4 Infectious Disease
7.2.1.5 Others
8 Global Respiratory Care Device Market Segmentation (2017-2032)
8.1 Global Respiratory Care Device Market (2017-2032) by Product
8.1.1 Market Overview
8.1.2 Therapeutic Respiratory Care Devices
8.1.2.1 Positive Airway Pressure (PAP) Devices
8.1.2.2 Oxygen Concentrator
8.1.2.3 Ventilators
8.1.2.4 Inhalers
8.1.2.5 Nebulizers
8.1.2.6 Humidifiers
8.1.2.7 Reusable Resuscitators
8.1.2.8 Nitric Oxide Delivery Units
8.1.2.9 Oxygen Hoods
8.1.3 Respiratory Care Monitoring Devices
8.1.3.1 Pulse Oximeter
8.1.3.2 Capnography
8.1.3.3 Gas Analyzers
8.1.4 Diagnostic Respiratory Care Devices
8.1.4.1 Spirometer
8.1.4.2 Polysomnography Devices
8.1.4.3 Peak Flow Meter
8.1.4.4 Others
8.2 Global Respiratory Care Device Market (2017-2032) by Disease Indications
8.2.1 Market Overview
8.2.2 COPD
8.2.3 Asthma
8.2.4 Sleep Apnea
8.2.5 Infectious Disease
8.2.6 Others
8.3 Global Respiratory Care Device Market (2017-2032) by End User
8.3.1 Market Overview
8.3.2 Hospitals
8.3.3 Home Care
8.3.4 Ambulatory Care
8.3.5 Others
8.4 Global Respiratory Care Device Market (2017-2032) by Region
8.4.1 Market Overview
8.4.2 North America
8.4.3 Europe
8.4.4 Asia Pacific
8.4.5 Latin America
8.4.6 Middle East and Africa
9 North America Respiratory Care Device Market (2017-2032)
9.1 North America Respiratory Care Device Market (2017-2032) by Product
9.1.1 Market Overview
9.1.2 Therapeutic Respiratory Care Devices
9.1.2.1 Positive Airway Pressure (PAP) Devices
9.1.2.2 Oxygen Concentrator
9.1.2.3 Ventilators
9.1.2.4 Inhalers
9.1.2.5 Nebulizers
9.1.2.6 Humidifiers
9.1.2.7 Reusable Resuscitators
9.1.2.8 Nitric Oxide Delivery Units
9.1.2.9 Oxygen Hoods
9.1.3 Respiratory Care Monitoring Devices
9.1.3.1 Pulse Oximeter
9.1.3.2 Capnography
9.1.3.3 Gas Analyzers
9.1.4 Diagnostic Respiratory Care Devices
9.1.4.1 Spirometer
9.1.4.2 Polysomnography Devices
9.1.4.3 Peak Flow Meter
9.1.4.4 Others
9.2 North America Respiratory Care Device Market (2017-2032) by Disease Indications
9.2.1 Market Overview
9.2.2 COPD
9.2.3 Asthma
9.2.4 Sleep Apnea
9.2.5 Infectious Disease
9.2.6 Others
9.3 North America Respiratory Care Device Market (2017-2032) by End User
9.3.1 Market Overview
9.3.2 Hospitals
9.3.3 Home Care
9.3.4 Ambulatory Care
9.3.5 Others
9.4 North America Respiratory Care Device Market (2017-2032) by Country
9.4.1 United States of America
9.4.2 Canada
10 Europe Respiratory Care Device Market (2017-2032)
10.1 Europe Respiratory Care Device Market (2017-2032) by Product
10.1.1 Market Overview
10.1.2 Therapeutic Respiratory Care Devices
10.1.2.1 Positive Airway Pressure (PAP) Devices
10.1.2.2 Oxygen Concentrator
10.1.2.3 Ventilators
10.1.2.4 Inhalers
10.1.2.5 Nebulizers
10.1.2.6 Humidifiers
10.1.2.7 Reusable Resuscitators
10.1.2.8 Nitric Oxide Delivery Units
10.1.2.9 Oxygen Hoods
10.1.3 Respiratory Care Monitoring Devices
10.1.3.1 Pulse Oximeter
10.1.3.2 Capnography
10.1.3.3 Gas Analyzers
10.1.4 Diagnostic Respiratory Care Devices
10.1.4.1 Spirometer
10.1.4.2 Polysomnography Devices
10.1.4.3 Peak Flow Meter
10.1.4.4 Others
10.2 Europe Respiratory Care Device Market (2017-2032) by Disease Indications
10.2.1 Market Overview
10.2.2 COPD
10.2.3 Asthma
10.2.4 Sleep Apnea
10.2.5 Infectious Disease
10.2.6 Others
10.3 Europe Respiratory Care Device Market (2017-2032) by End User
10.3.1 Market Overview
10.3.2 Hospitals
10.3.3 Home Care
10.3.4 Ambulatory Care
10.3.5 Others
10.4 Europe Respiratory Care Device Market (2017-2032) by Country
10.4.1 United Kingdom
10.4.2 Germany
10.4.3 France
10.4.4 Italy
10.4.5 Others
11 Asia Pacific Respiratory Care Device Market (2017-2032)
11.1 Asia Pacific Respiratory Care Device Market (2017-2032) by Product
11.1.1 Market Overview
11.1.2 Therapeutic Respiratory Care Devices
11.1.2.1 Positive Airway Pressure (PAP) Devices
11.1.2.2 Oxygen Concentrator
11.1.2.3 Ventilators
11.1.2.4 Inhalers
11.1.2.5 Nebulizers
11.1.2.6 Humidifiers
11.1.2.7 Reusable Resuscitators
11.1.2.8 Nitric Oxide Delivery Units
11.1.2.9 Oxygen Hoods
11.1.3 Respiratory Care Monitoring Devices
11.1.3.1 Pulse Oximeter
11.1.3.2 Capnography
11.1.3.3 Gas Analyzers
11.1.4 Diagnostic Respiratory Care Devices
11.1.4.1 Spirometer
11.1.4.2 Polysomnography Devices
11.1.4.3 Peak Flow Meter
11.1.4.4 Others
11.2 Asia Pacific Respiratory Care Device Market (2017-2032) by Disease Indications
11.2.1 Market Overview
11.2.2 COPD
11.2.3 Asthma
11.2.4 Sleep Apnea
11.2.5 Infectious Disease
11.2.6 Others
11.3 Asia Pacific Respiratory Care Device Market (2017-2032) by End User
11.3.1 Market Overview
11.3.2 Hospitals
11.3.3 Home Care
11.3.4 Ambulatory Care
11.3.5 Others
11.4 Asia Pacific Respiratory Care Device Market (2017-2032) by Country
11.4.1 China
11.4.2 Japan
11.4.3 India
11.4.4 ASEAN
11.4.5 Australia
11.4.6 Others
12 Latin America Respiratory Care Device Market (2017-2032)
12.1 Latin America Respiratory Care Device Market (2017-2032) by Product
12.1.1 Market Overview
12.1.2 Disposable Sensors
12.1.3 Reusable Probes
12.2 Latin America Respiratory Care Device Market (2017-2032) by Product Type
12.2.1 Market Overview
12.2.2 Therapeutic Respiratory Care Devices
12.2.2.1 Positive Airway Pressure (PAP) Devices
12.2.2.2 Oxygen Concentrator
12.2.2.3 Ventilators
12.2.2.4 Inhalers
12.2.2.5 Nebulizers
12.2.2.6 Humidifiers
12.2.2.7 Reusable Resuscitators
12.2.2.8 Nitric Oxide Delivery Units
12.2.2.9 Oxygen Hoods
12.2.3 Respiratory Care Monitoring Devices
12.2.3.1 Pulse Oximeter
12.2.3.2 Capnography
12.2.3.3 Gas Analyzers
12.2.4 Diagnostic Respiratory Care Devices
12.2.4.1 Spirometer
12.2.4.2 Polysomnography Devices
12.2.4.3 Peak Flow Meter
12.2.4.4 Others
12.3 Latin America Respiratory Care Device Market (2017-2032) by Disease Indications
12.3.1 Market Overview
12.3.2 COPD
12.3.3 Asthma
12.3.4 Sleep Apnea
12.3.5 Infectious Disease
12.3.6 Others
12.4 Latin America Respiratory Care Device Market (2017-2032) by End User
12.4.1 Market Overview
12.4.2 Hospitals
12.4.3 Home Care
12.4.4 Ambulatory Care
12.4.5 Others
12.5 Latin America Respiratory Care Device Market (2017-2032) by Country
12.5.1 Brazil
12.5.2 Argentina
12.5.3 Mexico
12.5.4 Others
13 Middle East and Africa Respiratory Care Device Market (2017-2032)
13.1 Middle East and Africa Respiratory Care Device Market (2017-2032) by Product
13.1.1 Market Overview
13.1.2 Therapeutic Respiratory Care Devices
13.1.2.1 Positive Airway Pressure (PAP) Devices
13.1.2.2 Oxygen Concentrator
13.1.2.3 Ventilators
13.1.2.4 Inhalers
13.1.2.5 Nebulizers
13.1.2.6 Humidifiers
13.1.2.7 Reusable Resuscitators
13.1.2.8 Nitric Oxide Delivery Units
13.1.2.9 Oxygen Hoods
13.1.3 Respiratory Care Monitoring Devices
13.1.3.1 Pulse Oximeter
13.1.3.2 Capnography
13.1.3.3 Gas Analyzers
13.1.4 Diagnostic Respiratory Care Devices
13.1.4.1 Spirometer
13.1.4.2 Polysomnography Devices
13.1.4.3 Peak Flow Meter
13.1.4.4 Others
13.2 Middle East Africa Respiratory Care Device Market (2017-2032) by Disease Indications
13.2.1 Market Overview
13.2.2 COPD
13.2.3 Asthma
13.2.4 Sleep Apnea
13.2.5 Infectious Disease
13.2.6 Others
13.3 Middle East and Africa Respiratory Care Device Market (2017-2032) by End User
13.3.1 Market Overview
13.3.2 Hospitals
13.3.3 Home Care
13.3.4 Ambulatory Care
13.3.5 Others
13.4 Middle East and Africa Respiratory Care Device Market (2017-2032) by Country
13.4.1 Saudi Arabia
13.4.2 United Arab Emirates
13.4.3 Nigeria
13.4.4 South Africa
13.4.5 Others
14 Regulatory Framework
14.1 Regulatory Overview
14.2 US FDA
14.3 EU EMA
14.4 INDIA CDSCO
14.5 JAPAN PMDA
14.6 Others
15 Patent Analysis
15.1 Analysis by Type of Patent
15.2 Analysis by Publication Year
15.3 Analysis by Issuing Authority
15.4 Analysis by Patent Age
15.5 Analysis by CPC Analysis
15.6 Analysis by Patent Valuation
15.7 Analysis by Key Players
16 Funding and Investment Analysis
16.1 Analysis by Funding Instances
16.2 Analysis by Type of Funding
16.3 Analysis by Funding Amount
16.4 Analysis by Leading Players
16.5 Analysis by Leading Investors
16.6 Analysis by Geography
17 Strategic Initiatives
17.1 Analysis by Partnership Instances
17.2 Analysis by Type of Partnership
17.3 Analysis by Leading Players
17.4 Analysis by Geography
18 Supplier Landscape
18.1 Market Share Analysis, By Region (Top 5 Companies)
18.1.1 Market Share Analysis: Global
18.1.2 Market Share Analysis: North America
18.1.3 Market Share Analysis: Europe
18.1.4 Market Share Analysis: Asia-Pacific
18.1.5 Market Share Analysis: Others
18.2 Koninklijke Philips N.V
18.2.1 Financial Analysis
18.2.2 Product Portfolio
18.2.3 Demographic Reach and Achievements
18.2.4 Mergers and Acquisitions
18.2.5 Certifications
18.3 Masimo Corporation
18.3.1 Financial Analysis
18.3.2 Product Portfolio
18.3.3 Demographic Reach and Achievements
18.3.4 Mergers and Acquisitions
18.3.5 Certifications
18.4 Teleflex Incorporated
18.4.1 Financial Analysis
18.4.2 Product Portfolio
18.4.3 Demographic Reach and Achievements
18.4.4 Mergers and Acquisitions
18.4.5 Certifications
18.5 Fisher & Paykel Healthcare Corporation Limited
18.5.1 Financial Analysis
18.5.2 Product Portfolio
18.5.3 Demographic Reach and Achievements
18.5.4 Mergers and Acquisitions
18.5.5 Certifications
18.6 Hamilton Medical AG
18.6.1 Financial Analysis
18.6.2 Product Portfolio
18.6.3 Demographic Reach and Achievements
18.6.4 Mergers and Acquisitions
18.6.5 Certifications
18.7 ICU Medical Inc.
18.7.1 Financial Analysis
18.7.2 Product Portfolio
18.7.3 Demographic Reach and Achievements
18.7.4 Mergers and Acquisitions
18.7.5 Certifications
18.8 General Electric Company
18.8.1 Financial Analysis
18.8.2 Product Portfolio
18.8.3 Demographic Reach and Achievements
18.8.4 Mergers and Acquisitions
18.8.5 Certifications
18.9 ResMed Inc.
18.9.1 Financial Analysis
18.9.2 Product Portfolio
18.9.3 Demographic Reach and Achievements
18.9.4 Mergers and Acquisitions
18.9.5 Certifications
18.10 Getinge AB
18.10.1 Financial Analysis
18.10.2 Product Portfolio
18.10.3 Demographic Reach and Achievements
18.10.4 Mergers and Acquisitions
18.10.5 Certifications
18.11 Aerin Medical Inc.
18.11.1 Financial Analysis
18.11.2 Product Portfolio
18.11.3 Demographic Reach and Achievements
18.11.4 Mergers and Acquisitions
18.11.5 Certifications
18.12 VitalAire Canada Inc.
18.12.1 Financial Analysis
18.12.2 Product Portfolio
18.12.3 Demographic
18.12.4 Mergers and Acquisitions
18.12.5 Certifications
19 Global Respiratory Care Device Market - Distribution Model (Additional Insight)
19.1 Overview
19.2 Potential Distributors
19.3 Key Parameters for Distribution Partner Assessment
20 Key Opinion Leaders (KOL) Insights (Additional Insight)

Companies Mentioned

  • Koninklijke Philips N.V
  • Masimo Corporation
  • Teleflex Incorporated
  • Fisher & Paykel Healthcare Corporation Limited
  • Hamilton Medical AG
  • ICU Medical Inc.
  • General Electric Company
  • ResMed Inc.
  • Getinge AB
  • Aerin Medical Inc.
  • VitalAire Canada Inc.

Methodology

Loading
LOADING...

Table Information